Form 4: Cidara Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Taylor Sandison, Chief Medical Officer of Cidara Therapeutics, sold shares to cover tax withholding obligations related to the vesting and settlement of RSUs.
Summary
- On March 11, 2024, Taylor Sandison, the Chief Medical Officer of Cidara Therapeutics, sold 20,662 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
- The shares were sold at a weighted average price of $0.6698, with individual transactions ranging from $0.66 to $0.67.
- Following the transaction, Sandison directly owns 347,095 shares of Cidara Therapeutics.
- This includes 4,000 shares acquired through the Employee Stock Purchase Plan (ESPP) on November 20, 2023.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly shift sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a routine practice among corporate executives and do not necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 11/20/2023 | 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) |
| 03/11/2024 | Taylor Sandison sold 20,662 shares of common stock to cover tax obligations. |
| 03/12/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.